# Insulet Corporation  Share Price Target ‘$236.83’, now 43.5% Upside Potential

- Link: https://www.directorstalkinterviews.com/insulet-corporation-share-price-target-236.83-now-43.5-upside-potential/4121150964
- Published: 2024-04-09T15:23:59+01:00
- Author: Charlotte Edwards

**Insulet Corporation** with ticker code (PODD) have now 18 market analysts covering
the stock. The analyst consensus now points to a rating of ‘buy’. The range between
the high target price and low target price is between $270.00 and $208.00 calculating
the mean target share price we have $236.83. (at the time of writing). Now with 
the previous closing price of $165.00 this now indicates there is a potential upside
of 43.5%. The 50 day moving average now sits at $178.61 and the 200 day MA is $196.64.
The market cap for the company is 11.89B. The stock price for the company is currently
$170.04 USD

 The potential market cap would be $17,066,349,784 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 57.84, revenue per share of $24.33
and a 6.09% return on assets.

Insulet Corporation is primarily engaged in the development, manufacture and sale
of its Omnipod System, a continuous insulin delivery system for people with insulin-
dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System(
Classic Omnipod), the Omnipod DASH Insulin Management System (Omnipod DASH), and
the Omnipod 5 Automated Insulin Delivery System (Omnipod 5). The Omnipod System 
features a small, lightweight, self-adhesive disposable tubeless Omnipod device (
Pod) that the user fills with insulin and wears directly on the body for up to three
days at a time, which delivers personalized doses of insulin, and the Personal Diabetes
Manager (PDM) or Controller, a wireless, handheld device that programs the Pod with
the user’s personalized insulin-delivery instructions and wirelessly monitors the
Pod’s operation. The Company sells Pods to Amgen Inc. (Amgen) for use in the Neulasta
Onpro kit, a delivery system for Amgen’s Neulasta.

Share on: